JIP
CME icon

Jaffetilchin Investment Partners’s CME Group CME Stock Holding History

Jaffetilchin Investment Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$579K Sell
1,960
-16
-0.8% -$4.75K 0.03% 250
2025
Q4 		$539K Sell
1,976
-812
-29% -$221K 0.03% 259
2025
Q3 		$753K Sell
2,788
-440
-14% -$120K 0.05% 220
2025
Q2 		$890K Sell
3,228
-352
-10% -$95.7K 0.06% 194
2025
Q1 		$950K Buy
3,580
+643
+22% +$159K 0.07% 175
2024
Q4 		$682K Buy
2,937
+359
+14% +$82.6K 0.05% 198
2024
Q3 		$569K Sell
2,578
-15
-0.6% -$3.1K 0.04% 209
2024
Q2 		$510K Sell
2,593
-218
-8% -$45K 0.04% 212
2024
Q1 		$605K Sell
2,811
-154
-5% -$32.4K 0.05% 189
2023
Q4 		$625K Sell
2,965
-57
-2% -$12.2K 0.06% 187
2023
Q3 		$605K Buy
3,022
+51
+2% +$10.1K 0.07% 172
2023
Q2 		$551K Sell
2,971
-91
-3% -$16.8K 0.06% 187
2023
Q1 		$586K Buy
+3,062
New +$554K 0.07% 176
2022
Q3 		– Sell
-1,015
Closed -$208K – 320
2022
Q2 		$208K Buy
+1,015
New +$215K 0.02% 301
2022
Q1 		– Sell
-956
Closed -$218K – 330
2021
Q4 		$218K Sell
956
-398
-29% -$87.6K 0.02% 318
2021
Q3 		$262K Sell
1,354
-3
-0.2% -$608 0.03% 293
2021
Q2 		$289K Buy
1,357
+23
+2% +$4.86K 0.02% 325
2021
Q1 		$272K Buy
+1,334
New +$263K 0.03% 285
2018
Q4 		– Sell
-2,640
Closed -$449K – 270
2018
Q3 		$449K Sell
2,640
-122
-4% -$20.5K 0.09% 171
2018
Q2 		$453K Sell
2,762
-947
-26% -$155K 0.1% 178
2018
Q1 		$600K Buy
+3,709
New +$590K 0.13% 132
2017
Q4 		– Sell
-2,881
Closed -$391K – 242
2017
Q3 		$391K Buy
2,881
+63
+2% +$7.96K 0.09% 201
2017
Q2 		$353K Sell
2,818
-51
-2% -$6.1K 0.12% 151
2017
Q1 		$341K Buy
2,869
+51
+2% +$6.13K 0.09% 191
2016
Q4 		$325K Buy
+2,818
New +$314K 0.1% 179

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jaffetilchin Investment Partners's CME Position: Q1 2026 in Review

Jaffetilchin Investment Partners reduced its CME Group (CME) stake by 0.81% in Q1 2026, selling an estimated $4.75K and leaving 1,960 shares worth $579K. The position accounts for 0.03% of the portfolio, ranked #250.

Jaffetilchin Investment Partners first reported a position in CME in Q4 2016 and has held it in 25 quarters since. The position peaked at $950K in Q1 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Jaffetilchin Investment Partners held 1,960 shares of CME Group worth $579K as of Q1 2026.
  • Jaffetilchin Investment Partners sold 16 CME Group shares in Q1 2026, an estimated $4.75K.
  • CME Group made up 0.03% of Jaffetilchin Investment Partners's portfolio in Q1 2026, its #250 holding.
  • Jaffetilchin Investment Partners first reported a position in CME Group in Q4 2016 and has held it in 25 quarters since.
  • Jaffetilchin Investment Partners's CME Group position peaked at $950K in Q1 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Jaffetilchin Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.